Pengfei Wu

Harbin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma.

Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma.

Journal: Exploration (Beijing, China)
Published: February 14, 2024

Glioblastoma Cell-Derived lncRNA-Containing Exosomes Induce Microglia to Produce Complement C5, Promoting Chemotherapy Resistance.

Glioblastoma Cell-Derived lncRNA-Containing Exosomes Induce Microglia to Produce Complement C5, Promoting Chemotherapy Resistance.

Journal: Cancer immunology research
Published: April 02, 2021

Tumor Cell-Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA.

Tumor Cell-Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA.

Journal: Cancer immunology research
Published: February 04, 2020

NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer.

NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer.

Journal: Journal of hematology & oncology
Published: January 02, 2020

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.

Journal: Theranostics
Published: October 16, 2019

Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis.

Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis.

Journal: Cancer biology & medicine
Published: October 11, 2019

QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.

QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 24, 2019

Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways.

Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways.

Journal: Nature communications
Published: June 12, 2019

DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma.

DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma.

Journal: EBioMedicine
Published: September 29, 2018

Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.

Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.

Journal: Nature communications
Published: May 29, 2018

Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.

Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.

Journal: Journal of neuro-oncology
Published: May 11, 2018

A case of giant primary liposarcoma of esophagus

A case of giant primary liposarcoma of esophagus

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: January 25, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026